Status:
WITHDRAWN
Safety and Long-term Effects of COVID-19 Vaccines in Patients With Pulmonary Tumor
Lead Sponsor:
Guangdong Provincial People's Hospital
Conditions:
Lung Cancer
Pulmonary Nodule, Solitary
Eligibility:
All Genders
18-85 years
Brief Summary
The objective of this study is to assess the inoculation-related symptoms and long-term effects of COVID-19 vaccines in patients with lung cancer or pulmonary nodules in a real-world setting. The inve...
Detailed Description
This study will enroll lung cancer/pulmonary nodule patients or healthy people who had undergone standard vaccination procedures against SARS-CoV-2/COVID-19. This observatory study will apply an elect...
Eligibility Criteria
Inclusion
- Pulmonary nodule/lung cancer patients confirmed by CT or pathological examination, who have been vaccinated against the SARS-CoV-2
- Pulmonary nodule/lung cancer patients confirmed by CT or pathological examination, who are not vaccinated against the SARS-CoV-2
- Healthy people who have been vaccinated against the SARS-CoV-2
Exclusion
- Multiple malignancy in other parts of body;
- Infected with SARS-CoV-2 virus currently or in the past;
- Refuse to participate in this study.
Key Trial Info
Start Date :
May 4 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 31 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04894682
Start Date
May 4 2021
End Date
May 31 2022
Last Update
March 17 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, China, 510080